Trial update
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease: registry status update
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.